Overexpressing miR-4443 can reduce FSP1-mediated ferroptosis induced by cisplatin treatment and targeting miR-4443 can sensitize cisplatin-resistant NSCLC cells to cisplatin. The gene discussed is AIFM2; the disease is non-small cell lung carcinoma.